VigiLanz Names Patrick Spangler as Chief Financial Officer

MINNEAPOLIS--(BUSINESS WIRE)--

VigiLanz, a digital healthcare technology company headquartered in Minneapolis, announced today the appointment of Patrick Spangler as Chief Financial Officer.

Mr. Spangler joins VigiLanz with over 35 years of experience in financial management and over 28 years in the health care IT and medical device industries. Before joining VigiLanz, he served as Chief Financial Officer of Healthland, Inc., a nationwide provider of comprehensive enterprise software for rural and critical access hospitals. Prior to his tenure at Healthland, he served as SVP and CFO for Epocrates, a public company purchased by athenahealth which delivered the leading mobile drug reference application, supporting more than fifty percent of U.S. physicians on a daily basis. He also served as SVP and CFO of ev3, Inc., a public company purchased by Covidien, serving the neurovascular and peripheral vascular markets. Prior to ev3 he served in various capacities at Medtronic Inc.

“Pat's strong background in the health care tech sector is extremely valuable as we continue to reinforce VigiLanz' market-leading real-time clinical intelligence and surveillance software platform,” said David Goldsteen, M.D., president and chief executive officer of VigiLanz. “Pat is an exceptional leader and financial executive, with a proven track record for helping drive rapid growth through successful operational, corporate finance and strategic business development activities.”

Mr. Spangler has a Bachelor's of science degree in accounting from the University of Minnesota, a Master of Business Taxation from the University of Minnesota, and a Master of Business Administration from University of Chicago. He also serves on the Board of Directors of Urologix Inc. ULGX, a Minneapolis-based provider of medical products.

About VigiLanz
VigiLanz Corporation (www.vigilanzcorp.com) is a privately held, emerging growth firm and a leading provider of clinical decision support software for hospitals, founded by David Goldsteen, M.D. and David Klass, M.D. in 2001. VigiLanz supports a community of hospital quality teams, infections disease and control specialists, pharmacists, and other clinicians dedicated to patient care. VigiLanz is helping transform 21^st century health care and assisting emerging Accountable Care Organizations better manage patient communities through real-time clinical information.